Cargando…

New prospects for incretin‐related drugs in the treatment of type 2 diabetes

This article is about new prospects for incretin‐related drugs in the treatment of type 2 diabetes. [Image: see text]

Detalles Bibliográficos
Autores principales:	Kimura, Tomohiko, Kaku, Kohei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	JDI Updates
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264388/ https://www.ncbi.nlm.nih.gov/pubmed/33151639 http://dx.doi.org/10.1111/jdi.13460

Ejemplares similares

The journey to understanding incretin systems: Theory, practice and more theory
por: Yabe, Daisuke, et al.
Publicado: (2019)

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
por: Matsuzaka, Takashi, et al.
Publicado: (2020)

A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis
por: Hotta, Nigishi
Publicado: (2019)

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020)

Cardiovascular disease in patients with type 2 diabetes
por: Jeon, Ja Young, et al.
Publicado: (2022)

Updates in diabetic neuropathy: A call for new diagnostic and treatment approaches
por: Aso, Yoshimasa
Publicado: (2021)

In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
por: Lee, Chi‐Ho, et al.
Publicado: (2020)

Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia
por: Seino, Yusuke, et al.
Publicado: (2019)

Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
por: Himeno, Tatsuhito, et al.
Publicado: (2019)

Recent evidence in the etiology and treatment for diabetic kidney disease
por: Shikata, Kenichi
Publicado: (2020)

Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
por: Lin, Kuan‐Yu, et al.
Publicado: (2021)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
por: Kawamori, Dan
Publicado: (2020)

New perspectives on insulin therapy
por: Araki, Eiichi, et al.
Publicado: (2020)

Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
por: Nakamura, Toshihiro, et al.
Publicado: (2020)

Diabetic kidney disease: Its current trends and future therapeutic perspectives
por: Koya, Daisuke
Publicado: (2019)

One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Recent updates and future perspectives on gestational diabetes mellitus: An important public health challenge
por: Chu, Leo Check Hei, et al.
Publicado: (2021)

Impaired insulin secretion and related factors in East Asian individuals
por: Nakamura, Akinobu, et al.
Publicado: (2021)

SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use
por: Hosokawa, Yusei, et al.
Publicado: (2020)

Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
por: Fujita, Yoshihito, et al.
Publicado: (2019)

Clinical evidence regarding factors linking metabolic abnormal obesity to pancreatic β‐cell dysfunction
por: Watada, Hirotaka
Publicado: (2020)

Obesity, metabolic syndrome and bariatric surgery: A narrative review
por: Jia, Weiping
Publicado: (2020)

Blood glucose control: Where are we?
por: Lee, Moon‐Kyu
Publicado: (2021)

Updates of incretin‐related drugs for the treatment of type 2 diabetes
por: Araki, Hirotaka, et al.
Publicado: (2022)

A new era of diabetic kidney disease treatment with sodium–glucose cotransporter‐2 inhibitors
por: Kume, Shinji, et al.
Publicado: (2022)

The era of continuous glucose monitoring and its expanded role in type 2 diabetes
por: Yu, Jin, et al.
Publicado: (2023)

Diet and exercise are a fundamental part of comprehensive care for type 2 diabetes
por: Yeh, Yun Kai, et al.
Publicado: (2023)

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
por: Khoo, Joan, et al.
Publicado: (2009)

Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
por: Kaneto, Hideaki, et al.
Publicado: (2020)

Update information on type 1 diabetes in children/adolescents and adults
por: Miura, Junnosuke, et al.
Publicado: (2023)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

Incretin Mimetics: Promising New Therapeutic Options in the Treatment of Type 2 Diabetes
por: Gleeson, Jeremy M., et al.
Publicado: (2005)

Stop that! It’s not Tourette’s but a new type of mass sociogenic illness
por: Müller-Vahl, Kirsten R, et al.
Publicado: (2021)

Community participatory learning and action cycle groups to reduce type 2 diabetes in Bangladesh (D:Clare): an updated study protocol for a parallel arm cluster randomised controlled trial
por: King, Carina, et al.
Publicado: (2023)

Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial
por: Thuraisingam, Sharmala, et al.
Publicado: (2019)

BENIGN BONE TUMORS AND TUMOR-LIKE BONE LESIONS: TREATMENT UPDATE AND NEW TRENDS
por: Nogueira Drumond, José Marcos
Publicado: (2015)

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives
por: Seino, Yutaka, et al.
Publicado: (2016)

Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine
por: Kaneto, Hideaki, et al.
Publicado: (2021)

Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan
por: De Livera, Alysha M., et al.
Publicado: (2020)

Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes
por: Schnabel, Catherine A, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_cpg6ub3972te32eut55o9iq8jf